Trials / Completed
CompletedNCT02998840
A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure
A Prospective, Vehicle Controlled, Double Blinded, Multicenter, Randomized, Phase II Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 132 (actual)
- Sponsor
- AOBiome LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate and compare the efficacy of B244 in treating patients with hypertension.
Detailed description
This is a Prospective, Vehicle Controlled, Double Blinded, Multicenter, Randomized Phase II trial, comparing the effect of twice daily B244 application for 4 weeks vs vehicle application on BP and inflammatory biomarkers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | B244 | odorless suspension |
| BIOLOGICAL | Vehicle | odorless suspension |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2017-04-25
- Completion
- 2017-06-26
- First posted
- 2016-12-21
- Last updated
- 2022-09-15
- Results posted
- 2022-08-15
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02998840. Inclusion in this directory is not an endorsement.